Primary Prevention of Sudden Cardiac Death: Trials in Patients with Coronary Artery Disease

Journal of Interventional Cardiac Electrophysiology

Volumn 9, Issue 2, 2003, Pages 203-206

  Buxton, Alfred E ^a   Ellison, Kristin E ^a   Kirk, Malcolm M ^a   Frain, Bryan ^a   Koo, Charles ^a   Gandhi, Gaurang ^a   Khouzam, Sameh ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Implanted cardioverter defibrillator; Sudden cardiac death

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PROCAINAMIDE;

CLINICAL TRIAL; CONFERENCE PAPER; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEFIBRILLATOR; FEMALE; HEALTH CARE COST; HUMAN; MALE; MORTALITY; MULTICENTER STUDY; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SUDDEN DEATH;

ARRHYTHMIA; CORONARY ARTERIOSCLEROSIS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HEART ARREST; HUMANS; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; STROKE VOLUME; UNITED STATES;

EID: 0242680366     PISSN: 1383875X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026236524273     Document Type: Conference Paper

References (11)

1. Zheng Z-J, Croft JB, Giles WH, et al. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001;104:2158-2163.
2. The Antiarrhythmics versus Implantable Defibrillators (AVID) investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. New England Journal of Medicine 1997;337:1576-1583.
3. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter automatic defibrillator implantation trial investigators. New England Journal of Medicine 1996;335:1933-1940.
4. Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. New England Journal of Medicine 1999;341:1882-1890.
5. Lee KL, Hafley G, Fisher JD, et al. Effect of implantable defibrillators on arrhythmic events and mortality in the multicenter unsustained tachycardia trial. Circulation 2002;106:233-238.
6. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002:NEJ-Moa013474.
7. Moss AJ, Fadl Y, Zareba W, et al. Survival benefit with an implanted defibrillator in relation to mortality risk in chronic coronary heart disease. American Journal of Cardiology 2001;88:516-520.
8. Bigger J. The Coronary Artery Bypass Graft (CABG) patch trial investigators. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after Coronary-Artery Bypass Graft Surgery. N Engl J Med 1997;337:1569-1575.
9. Bigger JT, Whang W, Rottman JN, et al. Mechanisms of death in the CABG patch trial. Circulation 1999;99:1416-1421.
10. Buxton AE, Lee KL, DiCarlo L, et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. New England Journal of Medicine 2000;342:1937-1945.
11. Ruskin JN, Camm AJ, Zipes DP, et al. Implantable cardioverter defibrillator utilization based on discharge diagnoses from medicare and managed care patients. Journal of Cardiovascular Electrophysiology 2002;13:38-43.